These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 17975024)
1. Pituitary-specific knockout of the Carney complex gene Prkar1a leads to pituitary tumorigenesis. Yin Z; Williams-Simons L; Parlow AF; Asa S; Kirschner LS Mol Endocrinol; 2008 Feb; 22(2):380-7. PubMed ID: 17975024 [TBL] [Abstract][Full Text] [Related]
2. PRKAR1A and the evolution of pituitary tumors. Kirschner LS Mol Cell Endocrinol; 2010 Sep; 326(1-2):3-7. PubMed ID: 20451576 [TBL] [Abstract][Full Text] [Related]
3. Pathology and molecular genetics of the pituitary gland in patients with the 'complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas' (Carney complex). Stratakis CA; Matyakhina L; Courkoutsakis N; Patronas N; Voutetakis A; Stergiopoulos S; Bossis I; Carney JA Front Horm Res; 2004; 32():253-64. PubMed ID: 15281351 [TBL] [Abstract][Full Text] [Related]
4. Use of mouse models to understand the molecular basis of tissue-specific tumorigenesis in the Carney complex. Kirschner LS J Intern Med; 2009 Jul; 266(1):60-8. PubMed ID: 19522826 [TBL] [Abstract][Full Text] [Related]
5. Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours. Kaltsas GA; Kola B; Borboli N; Morris DG; Gueorguiev M; Swords FM; Czirják S; Kirschner LS; Stratakis CA; Korbonits M; Grossman AB Clin Endocrinol (Oxf); 2002 Oct; 57(4):443-8. PubMed ID: 12354125 [TBL] [Abstract][Full Text] [Related]
6. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit (PRKAR1A) in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas" (Carney complex). Stratakis CA Ann N Y Acad Sci; 2002 Jun; 968():3-21. PubMed ID: 12119264 [TBL] [Abstract][Full Text] [Related]
7. Pituitary pathology in Carney complex patients. Stergiopoulos SG; Abu-Asab MS; Tsokos M; Stratakis CA Pituitary; 2004; 7(2):73-82. PubMed ID: 15761655 [TBL] [Abstract][Full Text] [Related]
8. Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex). Pack SD; Kirschner LS; Pak E; Zhuang Z; Carney JA; Stratakis CA J Clin Endocrinol Metab; 2000 Oct; 85(10):3860-5. PubMed ID: 11061550 [TBL] [Abstract][Full Text] [Related]
9. Germline deletion and a somatic mutation of the PRKAR1A gene in a Carney complex-related pituitary adenoma. Iwata T; Tamanaha T; Koezuka R; Tochiya M; Makino H; Kishimoto I; Mizusawa N; Ono S; Inoshita N; Yamada S; Shimatsu A; Yoshimoto K Eur J Endocrinol; 2015 Jan; 172(1):K5-10. PubMed ID: 25336503 [TBL] [Abstract][Full Text] [Related]
10. Pituitary pathology in patients with Carney Complex: growth-hormone producing hyperplasia or tumors and their association with other abnormalities. Boikos SA; Stratakis CA Pituitary; 2006; 9(3):203-9. PubMed ID: 17001464 [TBL] [Abstract][Full Text] [Related]
11. Mutation of Prkar1a causes osteoblast neoplasia driven by dysregulation of protein kinase A. Pavel E; Nadella K; Towns WH; Kirschner LS Mol Endocrinol; 2008 Feb; 22(2):430-40. PubMed ID: 17932105 [TBL] [Abstract][Full Text] [Related]
12. A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues. Kirschner LS; Kusewitt DF; Matyakhina L; Towns WH; Carney JA; Westphal H; Stratakis CA Cancer Res; 2005 Jun; 65(11):4506-14. PubMed ID: 15930266 [TBL] [Abstract][Full Text] [Related]
13. Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues. Biondi CA; Gartside MG; Waring P; Loffler KA; Stark MS; Magnuson MA; Kay GF; Hayward NK Mol Cell Biol; 2004 Apr; 24(8):3125-31. PubMed ID: 15060136 [TBL] [Abstract][Full Text] [Related]
17. Prkar1a haploinsufficiency ameliorates the growth hormone excess phenotype in Aip-deficient mice. Schernthaner-Reiter MH; Trivellin G; Roetzer T; Hainfellner JA; Starost MF; Stratakis CA Hum Mol Genet; 2020 Oct; 29(17):2951-2961. PubMed ID: 32821937 [TBL] [Abstract][Full Text] [Related]
18. Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/- or Rb1+/- backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signaling. Almeida MQ; Muchow M; Boikos S; Bauer AJ; Griffin KJ; Tsang KM; Cheadle C; Watkins T; Wen F; Starost MF; Bossis I; Nesterova M; Stratakis CA Hum Mol Genet; 2010 Apr; 19(8):1387-98. PubMed ID: 20080939 [TBL] [Abstract][Full Text] [Related]
19. Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice. Veugelers M; Wilkes D; Burton K; McDermott DA; Song Y; Goldstein MM; La Perle K; Vaughan CJ; O'Hagan A; Bennett KR; Meyer BJ; Legius E; Karttunen M; Norio R; Kaariainen H; Lavyne M; Neau JP; Richter G; Kirali K; Farnsworth A; Stapleton K; Morelli P; Takanashi Y; Bamforth JS; Eitelberger F; Noszian I; Manfroi W; Powers J; Mochizuki Y; Imai T; Ko GT; Driscoll DA; Goldmuntz E; Edelberg JM; Collins A; Eccles D; Irvine AD; McKnight GS; Basson CT Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14222-7. PubMed ID: 15371594 [TBL] [Abstract][Full Text] [Related]
20. Prkar1a gene knockout in the pancreas leads to neuroendocrine tumorigenesis. Saloustros E; Salpea P; Starost M; Liu S; Faucz FR; London E; Szarek E; Song WJ; Hussain M; Stratakis CA Endocr Relat Cancer; 2017 Jan; 24(1):31-40. PubMed ID: 27803029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]